New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- Myricetin ameliorates cytokine-induced migration and invasion of cholangiocarcin
- 1
- 5 years, 4 months ago
- lncRNAs as potential molecular biomarkers in the clinicopathology and prognosis
- 1
- 5 years, 4 months ago
- Interferon α-inducible protein 27 is an oncogene and highly expressed in cholang
- 1
- 5 years, 4 months ago
- Second primary malignancy in patients with cholangiocarcinoma: a population-base
- 1
- 5 years, 4 months ago
- Anatomical, histomorphological, and molecular classification of cholangiocarcino
- 1
- 5 years, 4 months ago
- Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenes
- 1
- 5 years, 4 months ago
- E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangio
- 1
- 5 years, 4 months ago
- Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In
- 1
- 5 years, 4 months ago
- LncRNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma t
- 1
- 5 years, 4 months ago
- Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepati
- 1
- 5 years, 4 months ago
- Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathwa
- 1
- 5 years, 4 months ago
- The forum ‘New Developments’ is closed to new topics and replies.